Skip to main content

. 1953 Feb 7;1(4805):296–299. doi: 10.1136/bmj.1.4805.296

Effect of Isoniazid on Carbohydrate Metabolism in Controls and Diabetics

G R W N Luntz, S G Smith

PMCID: PMC2015751 PMID: 13009181

296

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BENSON W. M., STEFKO P. L., ROE M. D. Pharmacologic and toxicologic observations on hydrazine derivatives of isonicotinic acid (rimifon, marsilid). Am Rev Tuberc. 1952 Apr;65(4):376–391. doi: 10.1164/art.1952.65.4.376. [DOI] [PubMed] [Google Scholar]
ELMENDORF D. F., Jr, CAWTHON W. U., MUSCHENHEIM C., McDERMOTT W. The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man. Am Rev Tuberc. 1952 Apr;65(4):429–442. doi: 10.1164/art.1952.65.4.429. [DOI] [PubMed] [Google Scholar]
Elsom K. O., Lukens F. D., Montgomery E. H., Jonas L. METABOLIC DISTURBANCES IN EXPERIMENTAL HUMAN VITAMIN B DEFICIENCY. J Clin Invest. 1940 Jan;19(1):153–161. doi: 10.1172/JCI101108. [DOI] [PMC free article] [PubMed] [Google Scholar]
PREZIOSI P. Interferenze fra isonicotilidrazide e zuccheri; considerazioni e ricerche preliminari. Riforma Med. 1952 Jun 28;66(26):706–709. [PubMed] [Google Scholar]
RUBIN B., HASSERT G. L., Jr, THOMAS B. G. H., BURKE J. C. Pharmacology of isonicotinic acid hydrazide (nydrazid). Am Rev Tuberc. 1952 Apr;65(4):392–401. doi: 10.1164/art.1952.65.4.392. [DOI] [PubMed] [Google Scholar]
SELIKOFF I. J., ROBITZEK E. H. Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Dis Chest. 1952 Apr;21(4):385–438. doi: 10.1378/chest.21.4.385. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES